FDA Inspection
AstraZeneca UK Ltd.AstraZeneca UK Ltd. – FDA Inspection, Aug 14, 2009
Record Details
This FDA Inspection record concerns AstraZeneca UK Ltd., with an inspection on August 14, 2009, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- AstraZeneca UK Ltd.
- Inspection Date
- August 14, 2009
- Product Type
- Drugs
View Company Profile
ID · 38cd0e2c-9dd9-4b44-8baf-79fe438e34b3
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 612417
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of AstraZeneca UK Ltd.
6| Date | Classification | Office | Project area |
|---|---|---|---|
| April 27, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 23, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 22, 2017 | Not classified | Office of Inspections and Investigations | |
| April 13, 2017 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 11, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for AstraZeneca UK Ltd.
- FDA Inspection 1274179 - 2023-04-27
- FDA Inspection 1129231 - 2020-02-23
- FDA Inspection 1030226 - 2017-09-22
- FDA Inspection 1017549 - 2017-04-13
- FDA Inspection 878183 - 2014-04-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.